High-dose daptomycin for the treatment of endocarditis caused by Staphylococcus aureus with intermediate susceptibility to glycopeptides.
Lichterfeld
Mathias
M
Ferraro
Mary Jane
MJ
Davis
Benjamin T
BT
D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use*; D017576:Daptomycin / Q000008:administration & dosage* / Q000627:therapeutic use*; D024881:Drug Resistance, Bacterial; D004697:Endocarditis, Bacterial / Q000188:drug therapy*; D006020:Glycopeptides / Q000494:pharmacology*; D006801:Humans; D013203:Staphylococcal Infections / Q000188:drug therapy*
D000900:Anti-Bacterial Agents; D006020:Glycopeptides; D017576:Daptomycin